Susquehanna International Group’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$167K Sell
10,810
-36,219
-77% -$560K ﹤0.01% 5655
2025
Q1
$699K Buy
47,029
+21,118
+82% +$314K ﹤0.01% 3871
2024
Q4
$343K Buy
25,911
+11,619
+81% +$154K ﹤0.01% 4587
2024
Q3
$203K Buy
+14,292
New +$203K ﹤0.01% 4796
2024
Q2
Sell
-10,569
Closed -$147K 6567
2024
Q1
$147K Sell
10,569
-28,069
-73% -$390K ﹤0.01% 4842
2023
Q4
$551K Buy
38,638
+27,323
+241% +$390K ﹤0.01% 3717
2023
Q3
$175K Buy
+11,315
New +$175K ﹤0.01% 4621
2023
Q2
Sell
-11,668
Closed -$192K 6430
2023
Q1
$192K Sell
11,668
-84,551
-88% -$1.39M ﹤0.01% 4899
2022
Q4
$1.5M Buy
96,219
+65,994
+218% +$1.03M ﹤0.01% 1878
2022
Q3
$392K Sell
30,225
-152,117
-83% -$1.97M ﹤0.01% 3876
2022
Q2
$2.56M Sell
182,342
-87,478
-32% -$1.23M ﹤0.01% 1428
2022
Q1
$3.86M Sell
269,820
-283,045
-51% -$4.05M ﹤0.01% 1377
2021
Q4
$7.54M Sell
552,865
-559,943
-50% -$7.63M ﹤0.01% 927
2021
Q3
$18.2M Sell
1,112,808
-17,950
-2% -$294K ﹤0.01% 505
2021
Q2
$19M Sell
1,130,758
-408,827
-27% -$6.88M ﹤0.01% 540
2021
Q1
$28.1M Buy
1,539,585
+523,298
+51% +$9.56M ﹤0.01% 350
2020
Q4
$18.5M Buy
1,016,287
+553,550
+120% +$10.1M ﹤0.01% 444
2020
Q3
$8.26M Buy
462,737
+64,450
+16% +$1.15M ﹤0.01% 617
2020
Q2
$7.14M Sell
398,287
-239,967
-38% -$4.3M ﹤0.01% 665
2020
Q1
$9.69M Buy
638,254
+483,226
+312% +$7.34M ﹤0.01% 419
2019
Q4
$3.06M Sell
155,028
-55,110
-26% -$1.09M ﹤0.01% 1109
2019
Q3
$3.61M Buy
210,138
+88,327
+73% +$1.52M ﹤0.01% 816
2019
Q2
$2.16M Buy
+121,811
New +$2.16M ﹤0.01% 1196
2019
Q1
Hold
0
4446
2018
Q4
Hold
0
4804